Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-03 Purchase |
2021-06-07 5:36 pm |
Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director |
96,153 | $3.12 | $299,997 | 43,077 (Indirect Direct) |
View |
| 2021-06-03 Purchase |
2021-06-07 5:25 pm |
Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer |
823,170 | $3.28 | $2,699,998 | 2,049,153 (Indirect Direct) |
View |
| 2021-06-03 Purchase |
2021-06-07 4:05 pm |
Cyclerion Therapeutics Inc. | CYCN | Slate Path Capital LP Greenspan David Gerald 10% Owner |
961,538 | $3.12 | $2,999,999 | 7,157,601 (Indirect) |
View |
| 2021-05-06 Purchase |
2021-05-10 08:45 am |
Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer |
302,000 | $2.43 | $733,860 | 1,225,983 (Indirect Direct) |
View |
| 2021-05-04 Purchase |
2021-05-06 9:27 pm |
Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer |
698,001 | $2.4268 | $1,693,943 | 923,983 (Indirect Direct) |
View |
| 2021-02-25 Sale |
2021-03-01 4:23 pm |
Cyclerion Therapeutics Inc. | CYCN | Gjino Anjeza Chief Financial Officer |
1,824 | $4 | $7,296 | 31,599 (Direct) |
View |
| 2021-02-25 Sale |
2021-03-01 4:17 pm |
Cyclerion Therapeutics Inc. | CYCN | Wright Christopher I Chief Medical Officer |
2,637 | $3.99 | $10,522 | 42,728 (Direct) |
View |
| 2020-12-28 Sale |
2020-12-30 1:14 pm |
Cyclerion Therapeutics Inc. | CYCN | Currie Mark G President and CSO |
20,107 | $3.01 | $60,522 | 251,648 (Direct) |
View |
| 2020-11-09 Purchase |
2020-11-12 5:05 pm |
Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Innovation Officer |
125,000 | $2.53 | $316,250 | 254,704 (Direct) |
View |
| 2020-11-06 Sale |
2020-11-10 7:07 pm |
Cyclerion Therapeutics Inc. | CYCN | Huyett William Chief Financial Officer |
3,827 | $2.52 | $9,644 | 67,590 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-24 Option Award |
2021-06-28 5:08 pm |
N/A 2031-06-24 |
Cyclerion Therapeutics Inc. | CYCN | DESOUZA ERROL B Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 5:05 pm |
N/A 2031-06-24 |
Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director |
10,000 | $0 | 10,000 (Direct) |
View |
Ownership |
2021-05-19 6:16 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | DESOUZA ERROL B Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-01-11 5:49 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Gjino Anjeza Chief Financial Officer |
0 | $0 | 232,006 (Direct) |
View |
Ownership |
2021-01-11 5:45 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Gault Cheryl Chief Operating Officer |
0 | $0 | 357,014 (Direct) |
View |
Ownership |
2020-12-30 9:53 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Wright Christopher I Chief Medical Officer |
0 | $0 | 414,645 (Direct) |
View |
| 2020-11-04 Option Award |
2020-11-06 4:43 pm |
N/A 2030-11-04 |
Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Innovation Officer |
75,000 | $0 | 75,000 (Direct) |
View |
Ownership |
2020-08-10 4:20 pm |
N/A N/A |
Cyclerion Therapeutics Inc. | CYCN | Slate Path Capital LP Greenspan David Gerald 10% Owner |
0 | $0 | 6,196,063 (Indirect) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:23 pm |
N/A 2030-06-16 |
Cyclerion Therapeutics Inc. | CYCN | Churchwell Kevin Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:22 pm |
N/A 2030-06-16 |
Cyclerion Therapeutics Inc. | CYCN | CONRADES GEORGE H Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:18 pm |
N/A 2030-06-16 |
Cyclerion Therapeutics Inc. | CYCN | Fanucci Marsha Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:17 pm |
N/A 2030-06-16 |
Cyclerion Therapeutics Inc. | CYCN | Isacson Ole Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:17 pm |
N/A 2030-06-16 |
Cyclerion Therapeutics Inc. | CYCN | Lovell Stephanie Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:16 pm |
N/A 2030-06-16 |
Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:16 pm |
N/A 2030-06-16 |
Cyclerion Therapeutics Inc. | CYCN | Mendelsohn Michael Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:15 pm |
N/A 2030-06-16 |
Cyclerion Therapeutics Inc. | CYCN | SCHULMAN AMY W Director |
10,000 | $0 | 10,000 (Direct) |
View |